Supplemental material
Open access
2,128
Views
5
CrossRef citations to date
0
Altmetric
Research Papers
Discovery of novel thiazolyl-pyrazolines as dual EGFR and VEGFR-2 inhibitors endowed with in vitro antitumor activity towards non-small lung cancer
Esraa A. Abdelsalama Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Helwan University, Cairo, EgyptCorrespondence[email protected] [email protected]
View further author information
, View further author information
Amer Ali Abd El-Hafeezb Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA;c Pharmacology and Experimental Oncology Unit, Department of Cancer Biology, National Cancer Institute, Cairo University, Cairo, EgyptCorrespondence[email protected] [email protected]
View further author information
, View further author information
Wagdy M. Eldehnad Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt;e School of Biotechnology, Badr University in Cairo, Badr City, Cairo, EgyptView further author information
, Mahmoud A. El Hassabf Department of Medicinal Chemistry, Faculty of Pharmacy, King Salman International University (KSIU), South Sinai, EgyptView further author information
, Hala Mohamed M. Marzoukb Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA;g Department of Biochemistry, Faculty of Medicine, Minia University, El-Minia, EgyptView further author information
, Mahmoud M. Elaasserh The Regional Center for Mycology and Biotechnology, Al-Azhar University, Cairo, EgyptView further author information
, Nageh A. Abou Taleba Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Helwan University, Cairo, EgyptView further author information
, Kamilia M. Amini Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Cairo, EgyptView further author information
, Hatem A. Abdel-Azizj Department of Applied Organic Chemistry, National Research Centre, Dokki, Giza, EgyptView further author information
, Pradipta Ghoshb Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA;k Department of Medicine, University of California San Diego, La Jolla, CA, USA;l Moores Comprehensive Cancer Center, University of California San Diego, La Jolla, CA, USA;m Veterans Affairs Medical Center, La Jolla, CA, USAView further author information
& Sherif F. Hammada Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Helwan University, Cairo, Egypt;n PharmD Program and Basic and Applied Sciences Institute, Egypt-Japan University of Science and Technology (E-JUST), Alexandria, EgyptCorrespondence[email protected]
View further author information
show allView further author information
Pages 2265-2282
|
Received 31 May 2022, Accepted 18 Jul 2022, Published online: 23 Aug 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.